Search

everythinglearnresearchcommunity

for

Search:↓

Women with more 3α,17β-androstanediol glucuronide compared to sex hormone binding globulin are more likely to have female pattern baldness.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.

Melanoma risk tools need improvement, certain gene mutations cause skin diseases and could be treated by targeting those mutations, skin wrinkling may relate to lung aging due to genetic factors, and oxidative stress affects hair loss but can be reduced in low oxygen.

Some women with acne have higher levels of free testosterone, which might suggest using hormonal treatments for acne.

Different types of polycystic ovary syndrome show varying levels of insulin resistance, with the 'PHO' type being the most insulin resistant.

Sex hormones and antiandrogens can either stimulate or inhibit human hair follicle cell growth depending on the dose.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Cuscuta reflexa extract may help treat hair loss caused by hormones.

Treatment during development affects hormone balance and sexual behavior in male rats.

Finasteride may improve prostate cancer treatment outcomes.

Dutasteride and finasteride affect different cell types differently.

Ovarian Leydig cell tumors are hard to diagnose with just advanced imaging; expert ultrasound and clinical evaluation are essential.

Doctors used a special blood sampling technique to diagnose a woman's rare ovarian tumor that was producing male hormones.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

Sebocytes play a key role in controlling androgen levels in human skin.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

One minoxidil-sensitive potassium channel exists in human hair follicles.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Reduced AR gene methylation may cause early pubic hair growth in girls.